{"id":"bisoxatin-acetate","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"exodol","offLabel":[],"synonyms":["bisoxatin acetate","exodol","lasotin","laxonalin"],"timeline":[],"brandName":"Exodol","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine Exodol as a key that fits into a lock on a protein in the body. When it binds to this protein, it helps to regulate a specific process, which can help to treat a particular disease or condition. This is a simplified explanation of how Exodol works at a molecular level.","oneSentence":"Exodol is a small molecule that works by interacting with a specific biological target to produce a therapeutic effect.","technicalDetail":"Exodol's mechanism of action is not well understood, but it is believed to involve the inhibition of a specific enzyme or receptor, leading to a cascade of downstream effects that ultimately result in its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/382","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BISOXATIN ACETATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:04:23.423208","biosimilars":[],"competitors":[],"genericName":"bisoxatin acetate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"79W5LFS83K","CHEBI":"CHEBI:31294","INN_ID":"2348","UMLSCUI":"C0613290","ChEMBL_ID":"CHEMBL2106004","KEGG_DRUG":"D01191","DRUGBANK_ID":"DB14654","PUBCHEM_CID":"26391","MESH_SUPPLEMENTAL_RECORD_UI":"C030065"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Exodol, also known as Bisoxatin Acetate, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a result, there is limited information available on its pharmacokinetic properties, such as half-life and bioavailability. Further research is needed to determine its potential therapeutic applications and safety profile. Exodol's development history is also unclear, with no information available on its original developer or current owner.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}